Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Share Buybacks
The buybacks for Labcorp Holdings Inc. (LH) is $450.00 Million with a year-over-year change of +79.93%. Share buybacks (stock repurchases) represent cash spent by the company to buy back its own shares in the open market, reducing shares outstanding and returning capital to shareholders.
LH Buybacks Chart
LH Buybacks
$450.00M-22.91% 20Y
Zoom
Current Buybacks
$450.00M
$450.00 Million
Year-over-Year Change
+79.93%
vs. $250.10M prior year
Historical Data
22
Years of data available
Annual Buybacks History
| Year | Buybacks | YoY Change | % Change |
|---|---|---|---|
| 2025 | $450.00M | +$199.90M | +79.93% |
| 2024 | $250.10M | $-789.70M | -75.95% |
| 2023 | $1.04B | $-110.80M | -9.63% |
| 2022 | $1.15B | $-517.90M | -31.04% |
| 2021 | $1.67B | +$1.53B | +1140.52% |
| 2020 | $134.50M | $-315.50M | -70.11% |
| 2019 | $450.00M | $-250.00M | -35.71% |
| 2018 | $700.00M | +$361.90M | +107.04% |
| 2017 | $338.10M | +$294.20M | +670.16% |
| 2016 | $43.90M | $-225.10M | -83.68% |
| 2014 | $269.00M | $-746.60M | -73.51% |
| 2013 | $1.02B | +$499.10M | +96.63% |
| 2012 | $516.50M | $-127.40M | -19.79% |
| 2011 | $643.90M | +$305.80M | +90.45% |
| 2010 | $338.10M | +$65.10M | +23.85% |
| 2009 | $273.00M | $-60.60M | -18.17% |
| 2008 | $333.60M | $-587.60M | -63.79% |
| 2007 | $921.20M | +$444.70M | +93.33% |
| 2006 | $476.50M | $-107.20M | -18.37% |
| 2005 | $583.70M | +$215.60M | +58.57% |
| 2004 | $368.10M | +$213.20M | +137.64% |
| 2003 | $154.90M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter